Teva's US results - impact on Mayne Pharma Share Price, page-19

pls see my post on other thread, should have posted it here instead perhaps as more relevant.

either way its oversold but i think from a sp perspective it will first get a little worse (80c or less), then a lot better just before results and then after, but then medium term we have substantial headwinds so myx may be stuck around $1 for a while yet.

very hard to predict now given the insanely bearish run from $2.10 to 80c despite almost zero negative news from the company directly and the management telling us its business as usual.

i hope its not going to be a repeat of the vocus saga where management said everything was fine and many of us held on until it was too late.

interesting times. thank god for gxy and web on friday...